Yantai Zhenghai Biotechnology Co., Ltd.

Equities

300653

CNE100002NZ1

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
23.85 CNY +2.27% Intraday chart for Yantai Zhenghai Biotechnology Co., Ltd. +6.90% -17.82%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023. CI
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Dividend for the Year 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhenghai Bio-Tech Gets Nod for Oral Restorative Film MT
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023. CI
Yantai Zhenghai Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares. CI
Yantai Zhenghai Biotechnology Co., Ltd. authorizes a Buyback Plan. CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Final Cash Dividend for the 2022 CI
Zhenghai Bio-Tech Enrolls First Subject for Uterine Cavity Repair Membrane Trial MT
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022 CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves Cash Dividend CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhenghai Bio-Tech Bumps 2021 Dividend by 252% on Double-Digit Earnings Growth MT
Yantai Zhenghai Biotechnology Co., Ltd. Proposes Distribution for 2021 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chart Yantai Zhenghai Biotechnology Co., Ltd.
More charts
Yantai Zhenghai Bio-Tech Co Ltd is a company engaged in production and sales of implantable medical devices. The Company has two types of products which are soft tissue repair materials and hard tissue repair materials. The soft tissue repair materials include oral repair membranes, biofilms and skin repair membranes. The hard tissue repair materials include bone repair materials.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.85 CNY
Average target price
31.34 CNY
Spread / Average Target
+31.38%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300653 Stock
  4. News Yantai Zhenghai Biotechnology Co., Ltd.
  5. Zhenghai Bio-Tech Enrolls First Subject for Uterine Cavity Repair Membrane Trial